HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Z Chen Selected Research

DEAE-Sepharose CL-6B

3/2001[Purification and immobilization of the proteinase from mung bean burgeon inactivating soybean trypsin inhibitor].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Z Chen Research Topics

Disease

129Neoplasms (Cancer)
07/2022 - 01/2000
49Infections
01/2022 - 01/2000
34Neoplasm Metastasis (Metastasis)
01/2022 - 01/2000
27Inflammation (Inflammations)
09/2021 - 04/2000
20Carcinogenesis
04/2020 - 05/2000
16Breast Neoplasms (Breast Cancer)
04/2020 - 10/2000
15Leukemia
01/2020 - 02/2000
15Acute Promyelocytic Leukemia
01/2011 - 02/2000
13Hepatocellular Carcinoma (Hepatoma)
11/2018 - 09/2000
13Carcinoma (Carcinomatosis)
02/2013 - 01/2000
12Prostatic Neoplasms (Prostate Cancer)
12/2018 - 12/2001
12Squamous Cell Carcinoma of Head and Neck
11/2016 - 05/2000
11Atopic Dermatitis (Atopic Eczema)
02/2022 - 01/2018
11Stomach Neoplasms (Stomach Cancer)
07/2020 - 05/2000
9Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2021 - 06/2000
9Ischemia
12/2020 - 10/2000
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 10/2000
9Hemorrhage
01/2019 - 03/2000
8Wounds and Injuries (Trauma)
03/2021 - 08/2000
8Pain (Aches)
01/2021 - 01/2003
8Hypoxia (Hypoxemia)
12/2020 - 07/2001
8Diabetes Mellitus
12/2019 - 06/2009
7Necrosis
03/2021 - 11/2000
7Reperfusion Injury
12/2020 - 08/2000
7Lung Neoplasms (Lung Cancer)
06/2017 - 02/2000
7Human Influenza (Influenza)
01/2015 - 06/2000
7Cardiovascular Diseases (Cardiovascular Disease)
05/2014 - 03/2001
6Liver Neoplasms (Liver Cancer)
10/2020 - 03/2001
6Colorectal Neoplasms (Colorectal Cancer)
06/2020 - 12/2006
5Heart Failure
05/2021 - 10/2003
5Ovarian Neoplasms (Ovarian Cancer)
05/2021 - 01/2001
5Hypersensitivity (Allergy)
01/2021 - 03/2000
5Burns
05/2020 - 08/2000
5Atherosclerosis
08/2019 - 07/2000
5Pneumonia (Pneumonitis)
03/2019 - 07/2001
5Thrombosis (Thrombus)
10/2018 - 07/2000
5Osteoporosis
01/2018 - 10/2003
5Type 2 Diabetes Mellitus (MODY)
10/2017 - 07/2009
5BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2017 - 01/2016
4Cicatrix (Scar)
04/2022 - 01/2011
4Stroke (Strokes)
01/2022 - 03/2001
4Obesity
01/2022 - 05/2014
4Hematoma
03/2021 - 05/2001
4Pruritus (Itching)
01/2021 - 01/2018

Drug/Important Bio-Agent (IBA)

69Proteins (Proteins, Gene)FDA Link
05/2021 - 03/2000
27Messenger RNA (mRNA)IBA
01/2017 - 01/2000
26CytokinesIBA
02/2022 - 01/2000
24DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2000
18Pharmaceutical PreparationsIBA
01/2019 - 06/2000
17Biomarkers (Surrogate Marker)IBA
01/2020 - 09/2000
14VaccinesIBA
01/2021 - 01/2000
14AntigensIBA
01/2018 - 01/2000
14Tretinoin (Retinoic Acid)FDA LinkGeneric
02/2004 - 02/2000
11dupilumabIBA
02/2022 - 01/2018
10Biological ProductsIBA
10/2020 - 05/2000
10Interleukin-6 (Interleukin 6)IBA
11/2018 - 01/2000
10Arsenic Trioxide (Trisenox)FDA Link
01/2011 - 02/2000
9EnzymesIBA
09/2017 - 06/2001
9Transcription Factors (Transcription Factor)IBA
01/2017 - 11/2000
9Complementary DNA (cDNA)IBA
04/2008 - 08/2000
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2020 - 02/2001
8Epidermal Growth Factor (EGF)IBA
04/2020 - 03/2000
8AntibodiesIBA
07/2017 - 08/2000
8Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2016 - 07/2000
8ChemokinesIBA
10/2015 - 07/2000
8NF-kappa B (NF-kB)IBA
02/2007 - 11/2000
7Cisplatin (Platino)FDA LinkGeneric
05/2021 - 03/2000
7MicroRNAs (MicroRNA)IBA
12/2020 - 01/2014
7CateninsIBA
10/2020 - 01/2011
7Monoclonal AntibodiesIBA
01/2020 - 01/2000
7Glucose (Dextrose)FDA LinkGeneric
06/2018 - 11/2001
6Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 11/2016
6Indicators and Reagents (Reagents)IBA
01/2022 - 03/2012
6Peptides (Polypeptides)IBA
05/2021 - 08/2001
6ErbB Receptors (EGF Receptor)IBA
07/2020 - 09/2003
6Insulin (Novolin)FDA Link
07/2020 - 06/2000
6RNA (Ribonucleic Acid)IBA
01/2020 - 05/2000
6Interleukin-10 (Interleukin 10)IBA
01/2020 - 08/2001
6LipidsIBA
01/2018 - 03/2001
6Small Interfering RNA (siRNA)IBA
01/2017 - 11/2006
6DNA VaccinesIBA
01/2008 - 06/2000
5Interleukin-13IBA
01/2020 - 01/2018
5InterleukinsIBA
01/2020 - 08/2001
5Immunoglobulin E (IgE)IBA
01/2019 - 01/2000
5Tyrosine Kinase InhibitorsIBA
03/2018 - 01/2016
5IntegrinsIBA
11/2017 - 04/2000
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2017 - 11/2000
5Cadherins (E-Cadherin)IBA
01/2017 - 09/2009
5Transforming Growth Factor beta (TGF-beta)IBA
01/2017 - 11/2000
5Transcription Factor AP-1 (Transcription Factor AP 1)IBA
11/2016 - 11/2000
5Phosphotransferases (Kinase)IBA
01/2016 - 08/2000
5ApolipoproteinsIBA
08/2015 - 07/2000
5Peptide Hydrolases (Proteases)FDA Link
07/2015 - 01/2000
5CaspasesIBA
08/2009 - 01/2000
5promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA
01/2007 - 01/2001
4oxidized low density lipoproteinIBA
07/2022 - 01/2017

Therapy/Procedure

66Therapeutics
02/2022 - 03/2000
21Drug Therapy (Chemotherapy)
01/2022 - 01/2000
14Radiotherapy
03/2018 - 02/2000
6Liver Transplantation
05/2012 - 12/2007